Trials / Completed
CompletedNCT01523717
Procalcitonin Monitoring Sepsis Study
Procalcitonin Decrease Over 72 Hours and Outcome in Patients With Severe Sepsis or Septic Shock
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 858 (actual)
- Sponsor
- Brahms AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the relationship between a procalcitonin decrease over 72 hours and outcome in patients who have severe sepsis or septic shock.
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2012-02-01
- Last updated
- 2015-03-17
Locations
13 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01523717. Inclusion in this directory is not an endorsement.